S&P 500
5,921.54
+2.0%
+$118.72
DJI
42,343.65
+1.8%
+$740.58
NASDAQ
19,199.16
+2.5%
+$461.96
Bitcoin
108,893.00
-0.0%
-41.51
AAPL
$200.00
+2.4%
+$4.73
AMZN
$205.78
+2.4%
+$4.79
GOOG
$173.90
+2.5%
+$4.32
META
$641.62
+2.3%
+$14.56
MSFT
$460.09
+2.2%
+$9.91
NVDA
$135.32
+3.1%
+$4.03
TSLA
$361.87
+6.6%
+$22.53
Nurix Therapeutics (NASDAQ: NRIX)
$9.78
(0.6%)
$0.06
Price as of May 27, 2025, 3:58 p.m. ET
Nurix Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Nurix Therapeutics Company Info
Nurix Therapeutics, Inc. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company was founded by John Kuriyan, Michael Rapé, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.